Cargando…
Treatment Outcome of Breast Cancer with Pathologically Proven Synchronous Ipsilateral Supraclavicular Lymph Node Metastases
PURPOSE: The aim of this study was to investigate the prognosis, patterns of failure, and prognostic factors for breast cancer patients with pathologically proven synchronous ipsilateral supraclavicular lymph node (ISCLN) metastases. METHODS: We reviewed the records of breast cancer patients with pa...
Autores principales: | Jung, Jinhong, Kim, Su Ssan, Ahn, Seung Do, Lee, Sang-wook, Ahn, Sei-Hyun, Son, Byung Ho, Lee, Jong Won, Choi, Eun Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490266/ https://www.ncbi.nlm.nih.gov/pubmed/26155293 http://dx.doi.org/10.4048/jbc.2015.18.2.167 |
Ejemplares similares
-
Comparison of Survival Outcomes Among Patients With Breast Cancer With Distant vs Ipsilateral Supraclavicular Lymph Node Metastases
por: Pan, Hong, et al.
Publicado: (2021) -
ASO Author Reflections: Impact of Ipsilateral Supraclavicular Lymph Node Dissection on Breast Cancer
por: Lv, Minhao, et al.
Publicado: (2021) -
Integration the biologic factors into the staging of breast cancer patients with ipsilateral supraclavicular lymph node metastasis
por: Lian, Chen-Lu, et al.
Publicado: (2020) -
Synchronous metastasis from double primary cancers in a single left supraclavicular lymph node
por: Kim, Ye An, et al.
Publicado: (2017) -
Breast Cancer Patients With Positive Apical or Infraclavicular/Ipsilateral Supraclavicular Lymph Nodes Should Be Excluded in the Application of the Lymph Node Ratio System
por: Wang, Zhe, et al.
Publicado: (2022)